Analysts who follow Lexicon Pharmaceuticals, Inc. (LXRX) on average expect it to gain 63.05% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns Lexicon Pharmaceuticals, Inc. an Analyst Ranking of 23, which means it ranks higher than 23 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Lexicon Pharmaceuticals, Inc. Stock Today?
Lexicon Pharmaceuticals, Inc. (LXRX) stock is down -0.99% while the S&P 500 is up 1.54% as of 10:10 AM on Monday, Sep 28. LXRX is lower by -$0.01 from the previous closing price of $1.52 on volume of 362,465 shares. Over the past year the S&P 500 has gained 12.51% while LXRX is lower by -49.83%. LXRX earned $0.19 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 7.9.
Click Here to get the full report on Lexicon Pharmaceuticals, Inc. (LXRX) Stock.
